A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients

NCT02492789 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors and Hematologic Malignancy

Interventions

BIOLOGICAL: INCSHR01210 injection

Sponsor

Atridia Pty Ltd.